L26/P-050 Revisiting the role of sperm DNA fragmentation in assisted reproductive technologies: an updated systematic review and meta-analysis
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.386 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M. Xu und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Study question What is the association between sperm DNA fragmentation (SDF) and clinical outcomes in assisted reproductive technologies (ART)? Summary answer Current evidence indicates that SDF levels significantly influence overall ART outcomes, but the magnitude and consistency of these influences varied across different settings. What is known already Sperm DNA integrity is widely recognized as a key determinant of male fertility potential and pregnancy outcomes, and there is growing evidence that SDF testing may provide clinical value in the context of ART. However, there is currently no consensus regarding the routine clinical application of SDF testing. Given the continuous emergence of new large-scale clinical studies, an updated synthesis of the available evidence is timely and warranted. Study design, size, duration We conducted a systematic review and meta-analysis incorporating the most recent evidence to evaluate the effects of SDF on a broad range of ART clinical outcome. This meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and the Cochrane Handbook for Systematic Reviews of Interventions. Three electronic databases (PubMed, EMBASE, and Cochrane Library) were searched from inception to 25 January 2026. Participants/materials, setting, methods Eighty-two eligible studies comprising 64,961 intrauterine insemination (IUI)/in vitro fertilization (IVF)-embryo transfer (ET)/intracytoplasmic sperm injection (ICSI)-ET cycles were included. Data on aneuploidy, implantation, biochemical/clinical pregnancy, miscarriage, live birth, preterm birth, newborn defect, and low birth weight were extracted. Subgroup analyses were conducted according to predefined characteristics: (1) Treatments-IUI/IVF/ICSI, (2) Assays-sperm chromatin dispersion assay (SCD)/sperm chromatin structure assay (SCSA)/Comet assay/terminal deoxynucleotidyl transferase dUTP nick end labeling assay (TUNEL), and (3) Cut-off values-15%/30%. Main results and the role of chance Overall, higher SDF levels were significantly associated with poorer clinical outcomes, including implantation rate (IR, 19 estimates, Odds ratio [OR]=0.69, p < 0.001), biochemical pregnancy rate (BPR, 43 estimates, OR = 0.88, p = 0.02), clinical pregnancy rate (CPR, 59 estimates, OR = 0.79, p < 0.001), and live birth rate (LBR, 31 estimates, OR = 0.86, p = 0.01), and with increased aneuploidy rate (AR, 4 estimates, OR = 1.67, p < 0.001) and miscarriage rate (MR, 45 estimates, OR = 1.25, p = 0.005). However, no significant associations were observed between SDF with neonatal outcomes, including preterm birth rate (8 estimates, OR = 1.20, p = 0.06), low birth weight rate (8 estimates, OR = 1.16, p = 0.16), and newborn defect rate (7 estimates, OR = 1.88, p = 0.13). In IUI subgroup, only BPR (OR = 0.51) and CPR (OR = 0.43) showed statistically significant associations. The IVF subgroup demonstrated significantly decreased IR (OR = 0.67) and CPR (OR = 0.71), while the ICSI subgroup showed another increase in MR (OR = 1.41). When stratified by cut-off values, a 30% threshold identified significant differences in IR (OR = 0.69), BPR (OR = 0.89), CPR (OR = 0.85), and LBR (OR = 0.85), while a 15% threshold distinguished only IR (OR = 0.68). Additionally, although the overall analyses of BPR and LBR indicated adverse effects of elevated SDF, no significant associations were observed when stratified by individual SDF assay. Limitations, reasons for caution Heterogeneity across studies may be attributable to difference in participant selection, assay methods, and SDF cut-off values. Although the overall analyses of major clinical outcomes included large datasets, subgroup analyses and some other outcomes remained limited by small sample sizes. Wider implications of the findings In this review, we incorporated the latest evidence and included the largest number of treatment cycles to date. Current evidence indicates that elevated SDF adversely affects ART outcomes, but the magnitude and consistency of these effects varied across subgroups. More well-designed studies are required to draw definitive conclusions. Trial registration number Yes
Zitieren
APA
Xu, M., Wang, S., Fung, K., Chan, C., Chung, J., & Chan, D. (2026). L26/P-050 Revisiting the role of sperm DNA fragmentation in assisted reproductive technologies: an updated systematic review and meta-analysis. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.386
Vancouver
Xu M, Wang S, Fung K, Chan C, Chung J, Chan D. L26/P-050 Revisiting the role of sperm DNA fragmentation in assisted reproductive technologies: an updated systematic review and meta-analysis. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.386
BibTeX
@article{Xu2026,
author = {Xu, M. and Wang, S. and Fung, K.K. and Chan, C.P.S. and Chung, J.P.W. and Chan, D.Y.L.},
title = {L26/P-050 Revisiting the role of sperm DNA fragmentation in assisted reproductive technologies: an updated systematic review and meta-analysis},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.386}
}
EUVIMED